DCAF11 and osteosarcoma: Mechanistically, TSC01682 significantly inhibits osteosarcoma cell proliferation and invasion by downregulating DCAF11 and DCAF13 and upregulating CDKN1A (cyclin-dependent kinase inhibitor 1A, also known as p21) and PTEN [51].